| | |

Predicting the Risk of Death from Mesothelioma

ByAlex Strauss
Predicting the risk of death from mesothelioma

New research suggests that the risk of death from mesothelioma does not always hinge on disease type or overall health.

Researchers in Brazil and at Mayo Clinic have identified some subtle mesothelioma risk factors that only pathologists can see.

These factors go beyond the characteristics of the mesothelioma cells themselves. The study shows the environment around the tumor, the number and type of immune system cells at the tumor site, and even how many cells are in the tumor can all impact the risk of death from mesothelioma. 

Understanding the Risk Factors for Mesothelioma

Asbestos exposure causes most cases of mesothelioma. But not everyone who encounters asbestos gets cancer. Genes and certain lifestyle factors may influence whether an exposed person contracts malignant mesothelioma. 

The same is true for the risk of death from mesothelioma. Not everyone who receives a mesothelioma diagnosis will die of the disease. Some people, like Paul Kraus, the world’s longest living mesothelioma survivor, live for decades after their diagnosis. 

Scientists know that people with the sarcomatoid or biphasic mesothelioma subtypes have a higher risk of death from mesothelioma. These subtypes tend to be less responsive to treatment. 

But other factors are not as obvious. A cluster of patients in the Bralizian study had a higher risk of death from mesothelioma. This risk was independent of other known mortality risk factors. 

Cluster of Patients with Higher Risk of Death from Mesothelioma

The Brazilian and Mayo researchers examined tumor tissue from 82 mesothelioma patients. 

They used a variety of high-end tests including immunohistochemistry, immunofluorescence, and morphometry to evaluate the tumors. Scientists call features of tumor cells “clinicopathologic features.”

The researchers found that two clusters of patients died at higher rates than the other mesothelioma patients. But their higher risk of death from mesothelioma had nothing to do with any features of their mesothelioma cells. 

The high-risk patients tended to have tumors with:

  • A higher density of mesothelioma cells 
  • High type V collagen fiber density (Col V)
  • Low CD8+ T lymphocytes in the area around the tumor

The patients with one of these characteristics were 2.19 times more likely than other patients to die of mesothelioma within 40 months. 

Pathologists can easily see these things if they know to look for them. The researchers conclude that these three factors can help doctors identify high risk patients. 

“Morphometric analysis of Col V, CD8+ T lymphocytes, and tumor cellularity can be used to identify patients with high risk of death from mesothelioma,” writes lead author Marcelo Luiz Balancin of the University of Sao Paulo.

Mesothelioma prognosis is another name for mortality risk. Having a clear picture of a mesothelioma patient’s prognosis can help doctors and patients plan the best treatment approach. 

Source:

Balancin, M, et al, “An Integrative Histopathologic Clustering Model Based on Immuno-Matrix Elements to Predict the Risk of Death in Malignant Mesothelioma”, May 11, 2020, Cancer Medicine, https://onlinelibrary.wiley.com/doi/full/10.1002/cam4.3111

Similar Posts

  • |

    Mesothelioma Blood Test May Be Possible

    ByAlex Strauss

    An international team of researchers is studying the proteins found on the surface of cancer cells in an effort to improve mesothelioma diagnosis. The team, made up of scientists from the US, Switzerland, Italy and Chile, has just published their findings on a new kind of test to identify protein-derived mesothelioma biomarkers in blood serum. Mesothelioma is an aggressive cancer of the membranes around organs. Because the most common mesothelioma biomarker, mesothelin, is also overproduced by other kinds of cancer cells, it has only limited diagnostic value. A test to identify a set of proteins produced specifically by mesothelioma cells could greatly improve diagnostic accuracy. Led by Ferdinando Cerciello and Bernd Wollscheid of the Institute of Molecular Systems Biology in…

  • |

    Mesothelioma Still Carries Heavy Mortality Burden in U.S.

    ByAlex Strauss

    Asbestos exposure cost Americans more than 427,000 years of potential life in the first decade of the new millennium. That figure comes from a study on mesothelioma and asbestosis – the two most deadly asbestos-related diseases – conducted by the CDC’s National Institute for Occupational Safety and Health (NIOSH). Using National Center for Health Statistics mortality data, NIOSH researchers evaluated premature deaths and “loss of potentially productive years of life” attributable to either asbestosis or mesothelioma between 1999 and 2010. The data included only people 25 years or older with an underlying cause of death listed on their death certificate of either asbestosis or malignant mesothelioma. When the figures were calculated using the normal life expectancy for each asbestosis victim…

  • | |

    Needle Biopsy “Simple, Safe & Accurate” for Mesothelioma

    ByAlex Strauss

    Mesothelioma researchers in China say a biopsy method that involves a single skin puncture can produce good diagnostic results for mesothelioma patients with little pain or risk. The study focused on percutaneous (through the skin) biopsy in patients who had unexplained fluid buildup or swelling in their abdomens. Abdominal distension and fluid buildup (called ascites) can be signs of peritoneal mesothelioma, a rare but aggressive cancer of the abdominal lining caused by exposure to asbestos. Peritoneal mesothelioma accounts for less than 30% of all mesothelioma cases. Because the symptoms may be vague and often develop many decades after asbestos exposure, peritoneal mesothelioma can be especially challenging to diagnose.  Misdiagnosis and under-diagnosis are not uncommon. In the newest study on percutaneous…

  • | |

    Inflammation Both “Friend and Foe” in Mesothelioma

    ByAlex Strauss

    An immune system response that causes mesothelioma symptoms such as fever, fatigue, and weight loss may also be helpful to clinicians as a way to find and treat the disease. Scientists with The Asbestos Diseases Research Institute in Sydney, Australia make that case that both systemic inflammation (throughout the body) and at the site of a tumor – has long been associated with mesothelioma and other cancers. Inflammation results when the body attempts to address the imbalances of cancer by producing more of certain immune system cells. Some inflammatory markers, such as CD+8 T-cells and C-reactive protein, have been linked to better prognosis in mesothelioma. Other inflammatory markers, such as certain macrophages and a high neutrophil-to-lymphocyte ratio, can signal the…

  • |

    Mesothelioma Rates Expected to Rise for Another Decade

    ByAlex Strauss

    Most developed countries can expect another decade or more of rising mesothelioma rates before the incidence of the disease starts to wane. That is one of the major findings in a recent report from The Baird Institute for Applied Heart and Lung Surgical Research in Australia. The report, which looked at the causes, distribution and projected future incidence of malignant mesothelioma, contains both good and bad news for the U.S.. Mesothelioma is an aggressive and often fatal cancer caused by exposure to asbestos.  It is thought to be triggered by chronic inflammation and irritation in the lung tissue and the surrounding pleural membrane by the sharp asbestos fibers.   Mesothelioma often takes decades to develop. According to the Baird Institute report, the average…

  • |

    Peritoneal Mesothelioma Study: Long-Term Survival is Possible

    ByAlex Strauss

    A new study out of Italy has some encouraging news for patients with the peritoneal form of malignant mesothelioma. The recent analysis of 108 peritoneal mesothelioma patients who underwent complete cytoreductive surgery (CRS) followed by a rinse of heated chemotherapy (HIPEC) found a 43.6% cure rate among long-term survivors. Peritoneal mesothelioma is a rare form of one of the rarest cancers. Triggered almost exclusively by exposure to asbestos, mesothelioma affects about 2,500 Americans each year.  About a third of those patients are diagnosed with the peritoneal form of the disease, which occurs on the membrane that lines the abdomen and surrounds the internal organs. During cytoreductive surgery, surgeons attempt to remove all traces of the mesothelioma tumor so that no cells…